Cargando…

Audit of clinical and laboratory parameters of hemoglobin SS patients in a Nigerian teaching hospital

BACKGROUND: The burden of Sickle cell anaemia (SCA) is huge in Sub Sahara Africa as it affects 1–2% of the population. HbSS impacts negatively on the quality of life of the sufferers. The clinical manifestations start between 3 and 5 months of life as a result of reduction in foetal hemoglobin. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Akingbola, Titilola Stella, Aworanti, Oladapo Wale, Ogundeji, Sunday Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665090/
https://www.ncbi.nlm.nih.gov/pubmed/36371797
http://dx.doi.org/10.1080/07853890.2022.2129090
_version_ 1784831219106578432
author Akingbola, Titilola Stella
Aworanti, Oladapo Wale
Ogundeji, Sunday Peter
author_facet Akingbola, Titilola Stella
Aworanti, Oladapo Wale
Ogundeji, Sunday Peter
author_sort Akingbola, Titilola Stella
collection PubMed
description BACKGROUND: The burden of Sickle cell anaemia (SCA) is huge in Sub Sahara Africa as it affects 1–2% of the population. HbSS impacts negatively on the quality of life of the sufferers. The clinical manifestations start between 3 and 5 months of life as a result of reduction in foetal hemoglobin. OBJECTIVES: This study describes the clinical and laboratory characteristics of HbSS patients at presentation in steady state, vaso-occlusive and hemolytic crises states. MATERIAL AND METHOD: This was a cross sectional, analytical study. Ninety HbSS participants were divided into three groups; steady state, hemolytic and vaso-occlusive crises with 30 individuals in each group. The survey contained sections on bio-data and past medical history obtained from the patients’ notes and results of laboratory tests. Data were analysed using SPSS version 23.0. Results were considered statistically significant if p < 0.05. RESULTS: Ninety participants were analysed in this study. The mean age of the participants was 29.4 ± 8.9 years. Only one-third of the participants were diagnosed within the first year of age. Forty-seven (52.2%) participants have steady state haematocrit in the range of 21–25%. All the participants experienced bone pain in a year, about 25% of these participants had more than three episodes of pain per year. There was a statistically significant difference in the mean values of PCV (p < .001), WBC (p < .001), platelet (p = .008), ANC (p < .001), ALC (p < .001), AMC (p < .001), reticulocyte count and ISC % among the different categories. CONCLUSION: This study established the fact that only a minority of the SCD patients are diagnosed in the first year of life and vaso-occlusive crisis is the most frequent reason for hospital presentation. We therefore recommend the institutionalisation by government policy, neonatal screening programme in Nigeria. KEY MESSAGES: The study highlight delay in early diagnosis of SCA due to unavailability of neonatal diagnosis program in our setting. Bone pain remains the major cause of presentation for SCA and most patients presented after a day of onset of pain to the hospital.
format Online
Article
Text
id pubmed-9665090
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-96650902022-11-15 Audit of clinical and laboratory parameters of hemoglobin SS patients in a Nigerian teaching hospital Akingbola, Titilola Stella Aworanti, Oladapo Wale Ogundeji, Sunday Peter Ann Med Hematology BACKGROUND: The burden of Sickle cell anaemia (SCA) is huge in Sub Sahara Africa as it affects 1–2% of the population. HbSS impacts negatively on the quality of life of the sufferers. The clinical manifestations start between 3 and 5 months of life as a result of reduction in foetal hemoglobin. OBJECTIVES: This study describes the clinical and laboratory characteristics of HbSS patients at presentation in steady state, vaso-occlusive and hemolytic crises states. MATERIAL AND METHOD: This was a cross sectional, analytical study. Ninety HbSS participants were divided into three groups; steady state, hemolytic and vaso-occlusive crises with 30 individuals in each group. The survey contained sections on bio-data and past medical history obtained from the patients’ notes and results of laboratory tests. Data were analysed using SPSS version 23.0. Results were considered statistically significant if p < 0.05. RESULTS: Ninety participants were analysed in this study. The mean age of the participants was 29.4 ± 8.9 years. Only one-third of the participants were diagnosed within the first year of age. Forty-seven (52.2%) participants have steady state haematocrit in the range of 21–25%. All the participants experienced bone pain in a year, about 25% of these participants had more than three episodes of pain per year. There was a statistically significant difference in the mean values of PCV (p < .001), WBC (p < .001), platelet (p = .008), ANC (p < .001), ALC (p < .001), AMC (p < .001), reticulocyte count and ISC % among the different categories. CONCLUSION: This study established the fact that only a minority of the SCD patients are diagnosed in the first year of life and vaso-occlusive crisis is the most frequent reason for hospital presentation. We therefore recommend the institutionalisation by government policy, neonatal screening programme in Nigeria. KEY MESSAGES: The study highlight delay in early diagnosis of SCA due to unavailability of neonatal diagnosis program in our setting. Bone pain remains the major cause of presentation for SCA and most patients presented after a day of onset of pain to the hospital. Taylor & Francis 2022-11-13 /pmc/articles/PMC9665090/ /pubmed/36371797 http://dx.doi.org/10.1080/07853890.2022.2129090 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hematology
Akingbola, Titilola Stella
Aworanti, Oladapo Wale
Ogundeji, Sunday Peter
Audit of clinical and laboratory parameters of hemoglobin SS patients in a Nigerian teaching hospital
title Audit of clinical and laboratory parameters of hemoglobin SS patients in a Nigerian teaching hospital
title_full Audit of clinical and laboratory parameters of hemoglobin SS patients in a Nigerian teaching hospital
title_fullStr Audit of clinical and laboratory parameters of hemoglobin SS patients in a Nigerian teaching hospital
title_full_unstemmed Audit of clinical and laboratory parameters of hemoglobin SS patients in a Nigerian teaching hospital
title_short Audit of clinical and laboratory parameters of hemoglobin SS patients in a Nigerian teaching hospital
title_sort audit of clinical and laboratory parameters of hemoglobin ss patients in a nigerian teaching hospital
topic Hematology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665090/
https://www.ncbi.nlm.nih.gov/pubmed/36371797
http://dx.doi.org/10.1080/07853890.2022.2129090
work_keys_str_mv AT akingbolatitilolastella auditofclinicalandlaboratoryparametersofhemoglobinsspatientsinanigerianteachinghospital
AT aworantioladapowale auditofclinicalandlaboratoryparametersofhemoglobinsspatientsinanigerianteachinghospital
AT ogundejisundaypeter auditofclinicalandlaboratoryparametersofhemoglobinsspatientsinanigerianteachinghospital